Fate Therapeutics
FATE
$3.88
Share price
2.04%
Change (1 day)
-36.12%
Change (1 year)
Categories
Fate Therapeutics (FATE) - Net assets
Net assets on the balance sheet as of December 2023 : $0.36 B
According to Fate Therapeutics
's latest financial reports the company has $0.36 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Fate Therapeutics - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.36 B | -23.87% |
| 2022-12-31 | $0.48 B | -28.71% |
| 2021-12-31 | $0.67 B | 76.58% |
| 2020-12-31 | $0.38 B | 57.07% |
| 2019-12-31 | $0.24 B | 52.53% |
| 2018-12-31 | $0.16 B | 107.89% |
| 2017-12-31 | $77.18 M | 5.52% |
| 2016-12-31 | $73.15 M | 92.32% |
| 2015-12-31 | $38.03 M | 34.22% |
| 2014-12-31 | $28.34 M | -44.27% |
| 2013-12-31 | $50.84 M | -196.26% |
| 2012-12-31 | $-52.83 M | 4.23% |
| 2011-12-31 | $-50.69 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | $25.33 B | 6,776.18% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $0.85 B | 133.25% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -$0.82 B | -322.18% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $2.23 B | 505.84% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.50 B | 35.92% | 🇺🇸 USA |